Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Buy

A

NovoCure Limited Ordinary Shares (NVCR)

Surgical & Medical Instruments & Apparatus

https://www.novocure.com

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Ovarian Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer, and Brain Metastasis. Products are comprised of two main components: electric field generator and arrays and related accessories. NovoCure derives its major revenues in the United States.

NO. 4 THE FORUM, GRENVILLE STREET
ST. HELIER, Y9

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/02/2015

Market Cap

1,929,509,110

Shares Outstanding

106,860,000

Weighted SO

106,861,113

Total Employees

N/A

Upcoming Earnings

07/25/2024

Similar Tickers

GMED --.--%

PODD --.--%

INSP --.--%

NARI --.--%

TMDX --.--%

INMD --.--%

ITGR --.--%

CNMD --.--%

Beta

0.6930

Last Div

0.0000

Range

10.87-31.73

Chg

-1.0800

Avg Vol

1471461

Mkt Cap

1929509110

Exch

NASDAQ

Country

JE

Phone

44 15 3475 6700

DCF Diff

16.2854

DCF

1.6446

Div Yield

0.0000

P/S

3.5084

EV Multiple

-18.8216

P/FV

5.3084

Div Yield %

0.0000

P/E

-11.3830

PEG

-1.0309

Payout

0.0000

Current Ratio

6.4597

Quick Ratio

6.2206

Cash Ratio

0.9957

DSO

42.9421

DIO

110.9950

Op Cycle

153.9370

DPO

247.4785

CCC

-93.5415

Gross Margin

0.7582

Op Margin

-0.3365

Pretax Margin

-0.2566

Net Margin

-0.3067

Eff Tax Rate

-0.1954

ROA

-0.1392

ROE

-0.4568

ROCE

-0.1775

NI/EBT

1.1954

EBT/EBIT

0.7625

EBIT/Rev

-0.3365

Debt Ratio

0.6043

D/E

2.0248

LT Debt/Cap

0.6437

Total Debt/Cap

0.6694

Int Coverage

-20.1863

CF/Debt

-0.0917

Equity Multi

3.3509

Rec Turnover

8.4998

Pay Turnover

1.4749

Inv Turnover

3.2884

FA Turnover

5.1268

Asset Turnover

0.4537

OCF/Share

-0.6236

FCF/Share

-0.9700

Cash/Share

8.8656

OCF/Sales

-0.1221

FCF/OCF

1.5554

CF Coverage

-0.0917

ST Coverage

-0.8501

CapEx Coverage

-1.8005

Div&CapEx Cov

-1.8005

P/BV

5.3084

P/B

5.3084

P/S

3.5084

P/E

-11.3830

P/FCF

-18.4695

P/OCF

-28.5903

P/CF

-28.5903

PEG

-1.0309

P/S

3.5084

EV Multiple

-18.8216

P/FV

5.3084

DPS

0.0000

Latest Headlines (EST)

The Motley Fool Sep 06, 21:19 Why NovoCure Stock Dived by 13% This Week Benzinga Jan 18, 14:22 AI Drives Tech Rebound, Oil Soars, Bitcoin Tumbles: What's Driving Markets Thursday? The Motley Fool Oct 26, 16:35 Why Novocure Stock Was Sick Today

Revenue Product Segmentation